Growth Metrics

Jazz Pharmaceuticals (JAZZ) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 133.08%
Dec 31, 2025 -13.53%
Sep 30, 2025 48.86%
Jun 30, 2025 -279.26%
Mar 31, 2025 12.57%
Dec 31, 2024 -190.28%
Sep 30, 2024 183.27%
Jun 30, 2024 5.45%
Mar 31, 2024 -367.10%
Dec 31, 2023 158.40%
Sep 30, 2023 -103.29%
Jun 30, 2023 -1,678.08%
Mar 31, 2023 98.51%
Dec 31, 2022 -7,148.63%
Sep 30, 2022 105.16%
Jun 30, 2022 -139.09%
Mar 31, 2022 -269.52%
Dec 31, 2021 62.36%
Sep 30, 2021 99.55%
Jun 30, 2021 -902.08%
Mar 31, 2021 906.75%
Dec 31, 2020 126.18%
Sep 30, 2020 62.27%
Jun 30, 2020 -1,133.63%
Mar 31, 2020 62.23%
Dec 31, 2019 0.38%
Sep 30, 2019 -5,952.35%
Jun 30, 2019 -101.59%
Mar 31, 2019 315.21%
Dec 31, 2018 120.86%
Sep 30, 2018 -0.61%
Jun 30, 2018 -265.46%
Mar 31, 2018 -63.59%
Dec 31, 2017 84.32%
Sep 30, 2017 -574.43%
Jun 30, 2017 -743.62%
Mar 31, 2017 -92.25%
Dec 31, 2016 99.88%
Sep 30, 2016 -642.26%
Jun 30, 2016 -1,619.61%
Mar 31, 2016 -256.25%
Dec 31, 2015 34.74%
Sep 30, 2015 57.09%
Jun 30, 2015 -165.72%
Mar 31, 2015 229.06%
Dec 31, 2014 82.95%
Sep 30, 2014 -533.05%
Jun 30, 2014 98.63%
Sep 30, 2013 -31.49%
Jun 30, 2013 -55.36%
Mar 31, 2013 -107.39%
Dec 31, 2012 2,425.66%
Sep 30, 2012 99.33%
Jun 30, 2012 -780.23%
Mar 31, 2012 225.78%
Dec 31, 2011 -381.57%
Sep 30, 2011 -1,561.22%
Jun 30, 2011 31.15%
Mar 31, 2011 -7.01%
Dec 31, 2010 -38.09%